Impact of repeated community-based selective chemotherapy on morbidity due to schistosomiasis mansoni.

No abstract is available for this paper.

• Publication year

  1994

• Venue

  American Journal of Tropical Medicine and Hygiene

• Publication date

  1994-11-01

• Fields of study

  Medicine, Environmental Science

• Identifiers
  DOI 10.4269/AJTMH.1994.51.634PMID 7985756
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Schistosomiasis mansoni in Burundi: progress in its control since 1985.

  1993cited by this paper
• Morbidity due to infection with Schistosoma mansoni: an update.

  1992cited by this paper
• Morbidity, due to schistosomiasis mansoni, and its control in Subsaharan Africa.

  1991cited by this paper
• The epidemiology of schistosomiasis in Burundi and its consequences for control.

  1991cited by this paper
• Repeated community-based chemotherapy for the control of Schistosoma mansoni: effect of screening and selective treatment on prevalences and intensities of infection.

  1991cited by this paper
• The morbidity of schistosomiasis mansoni in the highland focus of Lake Cohoha, Burundi.

  1990cited by this paper
• The relevance of schistosomiasis for public health.

  1989cited by this paper
• Eight years of targeted mass treatment of Schistosoma mansoni infection in Maniema, Zaire.

  1989cited by this paper
• Two-year follow-up of Schistosoma mansoni infection and morbidity after treatment with different regimens of oxamniquine and praziquantel.

  1989cited by this paper
• The morbidity of schistosomiasis mansoni in the Rusizi Plain (Burundi).

  1988cited by this paper
• The distribution of Schistosoma mansoni in the Rusizi plain (Burundi).

  1988cited by this paper
• Morbidity associated with Schistosoma mansoni infection as determined by ultrasound: a study in Gezira, Sudan.

  1988cited by this paper
• Reduction in prevalence, intensity of infection and morbidity due to Schistosoma mansoni infection in a community following treatment with praziquantel.

  1987cited by this paper
• The morbidity of schistosomiasis mansoni in Maniema (Zaire).

  1987cited by this paper
• [Drug resistance of Plasmodium falciparum in Burundi].

  1985cited by this paper
• [Epidemiology of malaria in the plain of Ruzizi, Burundi].

  1984cited by this paper

• Genetic analysis of praziquantel response in schistosome parasites implicates a Transient Receptor Potential channel

  2021cites this paper
• Elucidation of Cellular Responses in Non-human Primates With Chronic Schistosomiasis Followed by Praziquantel Treatment

  2020cites this paper
• Fifteen Years of Sm-p80-Based Vaccine Trials in Nonhuman Primates: Antibodies From Vaccinated Baboons Confer Protection in vivo and in vitro From Schistosoma mansoni and Identification of Putative Correlative Markers of Protection

  2020cites this paper
• Epidemiology of Schistosoma mansoni infection in Ituri Province, north-eastern Democratic Republic of the Congo

  2020cites this paper
• TREPAR 1597 No . of Pages 10 Diagnostic Tests for Urogenital Schistosomiasis

  2017cites this paper
• Diagnosing Urogenital Schistosomiasis: Dealing with Diminishing Returns.

  2017cites this paper
• Decline in infection-related morbidities following drug-mediated reductions in the intensity of Schistosoma infection: A systematic review and meta-analysis

  2017cites this paper
• Neglected Tropical Diseases - Sub-Saharan Africa

  2016cites this paper
• Acompanhamento clínico, epidemiológico e imunológico de pacientes portadores da fase aguda da esquistossomose mansoni, submetidos à terapêutica específica com Praziquantel

  2009cites this paper
• Cross-Reactivity of Schistosoma mansoni Cytosolic Superoxide Dismutase, a Protective Vaccine Candidate, with Host Superoxide Dismutase and Identification of Parasite-Specific B Epitopes

  2004cites this paper
• Vaccination with antioxidant enzymes confers protective immunity against challenge infection with Schistosoma mansoni.

  2004cites this paper
• The impact of chemotherapy on morbidity due to schistosomiasis.

  2003cites this paper
• The impact of repeated treatment with praziquantel of schistosomiasis in children under six years of age living in an endemic area for Schistosoma haematobium infection.

  2001cites this paper
• Double-blind placebo-controlled study of concurrent administration of albendazole and praziquantel in schoolchildren with schistosomiasis and geohelminths.

  1999cites this paper
• Day-to-day egg count fluctuation in Schistosoma mansoni infection and its operational implications.

  1996cites this paper
• Modelling human Schistosoma mansoni infection : the art of counting eggs in faeces

  1996cites this paper
• SCHISTOSIM: a microsimulation model for the epidemiology and control of schistosomiasis.

  1996cites this paper
• Control of Schistosoma mansoni and intestinal helminths: 8-year follow-up of an urban school programme in Bujumbura, Burundi.

  1994cites this paper